Humana Inc.

NYSE: HUM · Real-Time Price · USD
289.06
7.72 (2.74%)
At close: Aug 15, 2025, 12:46 PM

Humana Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
123.11B 120.26B 117.76B 115.01B 112.04B 109.24B 106.37B 102.35B 98.73B 95.64B 92.87B 91.48B 89.38B 86.37B 83.06B 81.07B 80.45B 78.89B
Cost of Revenue
3.34B 3.34B 3.34B 3.34B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
123.11B 120.26B 117.76B 115.01B 112.04B 109.24B 106.37B 102.35B 98.73B 95.64B 92.87B 91.48B 89.38B 86.37B 83.06B 81.07B 80.45B 78.89B
Operating Income
2.94B 3.34B 2.56B 2.76B 3.23B 3.53B 4.01B 4.49B 4.45B 4.23B 3.8B 3.74B 4.2B 4.22B 4.16B 3.75B 3.94B 5.13B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
2.13B 2.29B 1.63B 1.91B 2.36B 2.71B 3.32B 3.86B 4.07B 3.94B 3.56B 3.58B 3.93B 3.57B 3.42B 3.03B 3.17B 5.01B
Net Income
1.58B 1.71B 1.21B 1.36B 1.71B 1.99B 2.49B 3.02B 3.38B 3.12B 2.81B 2.81B 3.14B 3.04B 2.93B 2.67B 2.48B 3.72B
Selling & General & Admin
7.12B 10.2B 13.21B 12.76B 12.68B 12.71B 12.68B 12.66B 12.43B 12.29B 12.2B 12.23B 11.85B 11B 10.12B 9.79B 9.7B 9.94B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
113.05B 106.72B 101.98B 99.49B 96.12B 93B 89.68B 85.21B 81.84B 79.12B 76.87B 75.52B 73.33B 71.14B 68.79B 67.53B 66.81B 63.81B
Operating Expenses
120.17B 116.92B 115.2B 112.25B 108.8B 105.71B 102.36B 97.87B 94.28B 91.41B 89.07B 87.75B 85.18B 82.14B 78.91B 77.32B 76.51B 73.75B
Interest Expense
650M 661M 660M 642M 587M 539M 493M 455M 443M 424M 401M 384M 370M 348M 326M 307M 294M 291M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
120.17B 116.92B 115.2B 112.25B 108.8B 105.71B 102.36B 97.87B 94.28B 91.41B 89.07B 87.75B 85.18B 82.14B 78.91B 77.32B 76.51B 73.75B
Income Tax Expense
956M 1B 845M 704M 805M 878M 986M 969M 820M 951M 878M 871M 884M 640M 587M 714M 1.04B 1.64B
Shares Outstanding (Basic)
120.54M 120.41M 120.41M 120.41M 120.44M 120.98M 122.46M 123.43M 124.57M 125M 125.64M 126.57M 126.52M 126.94M 128.61M 128.52M 128.69M 128.93M
Shares Outstanding (Diluted)
120.75M 120.76M 120.76M 120.76M 120.67M 121.27M 122.46M 123.98M 125.11M 125.56M 125.64M 127.36M 127.08M 127.47M 128.61M 129.25M 129.39M 129.55M
EPS (Basic)
13.07 14.19 10.01 11.34 14.09 16.15 19.93 24.23 26.93 24.73 22.15 22.16 24.63 23.70 22.79 20.83 19.05 28.30
EPS (Diluted)
13.03 14.15 9.96 11.30 14.03 16.06 19.82 24.12 26.80 24.62 22.04 22.05 24.50 23.57 22.67 20.71 18.92 28.12
EBITDA
3.84B 4.12B 3.53B 3.72B 4.19B 4.47B 4.93B 5.38B 5.33B 5.09B 4.64B 4.56B 3.98B 3.96B 3.86B 3.42B 4.59B 5.77B
EBIT
2.93B 3.18B 2.56B 2.76B 3.23B 3.53B 4.01B 4.49B 4.45B 4.23B 3.8B 3.74B 3.19B 3.21B 3.15B 2.74B 3.94B 5.13B
Depreciation & Amortization
909M 941M 968M 966M 958M 941M 917M 896M 875M 858M 845M 822M 789M 750M 713M 679M 659M 639M